Augustina Isioma Ikusemoro: Thalassaemia is not Just a Blood Disorder – It is a Public Health Priority
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Thalassaemia is not just a blood disorder.
It is a public health priority.
Behind every statistic is a child, a family, and a lifelong journey of transfusions, monitoring, and hope.
This World Thalassaemia Day, we must remember:
- Thalassaemia is inherited — not contagious
- Millions worldwide are affected
- Many patients depend on lifelong transfusion support
- The disease places a major burden on families and healthcare systems
But here’s the powerful truth:
Many cases are preventable through:
- premarital screening
- genetic counselling
- early diagnosis
- public awareness
When communities understand the genetics, we reduce suffering, improve outcomes, and protect future generations.
This is why awareness matters.
This is why screening matters.
This is why equitable access to care matters.
Together, we can move from:
- delayed diagnosis – to early intervention
- stigma – to support
- silence – to advocacy
Because thalassaemia is not just a family problem.
It is a shared global responsibility.
— Signature of Blood Doki
Educate. Empower. Elevate.”

Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice
-
Nov 15, 2026, 15:03Francesco Antonio Veneziano: Rethinking Coronary Artery Disease Through Precision Cardiology
-
Nov 15, 2026, 14:37Denise Rezende: 100 Years of von Willebrand Disease and Advances in Diagnosis
-
Nov 15, 2026, 14:22Ahmed Alotaibi: Does Donor Sex Influence Platelet Storage Quality
-
Nov 15, 2026, 14:09Stephen Alerhand: Acute Pulmonary Embolism vs Chronic Pulmonary Hypertension
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility